Medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation

The studies in this thesis were aimed at developing new treatment concepts for PSII based on the understanding of the immunological mechanisms characterised in basic research. The intensity and prognosis of inflammatory disease determine the intensity of immunosuppressive therapy. In addition to cli...

Full description

Bibliographic Details
Main Author: Greiner, Kathrin Heike
Published: University of Aberdeen 2004
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.409246
id ndltd-bl.uk-oai-ethos.bl.uk-409246
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-4092462017-04-20T03:33:39ZMedical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammationGreiner, Kathrin Heike2004The studies in this thesis were aimed at developing new treatment concepts for PSII based on the understanding of the immunological mechanisms characterised in basic research. The intensity and prognosis of inflammatory disease determine the intensity of immunosuppressive therapy. In addition to clinical features, markers of effective immunosuppression are required to guide the immunosuppressive treatment in PSII patients, especially in those patients with opaque media. A secondary aim of this thesis was, hence, the evaluation of laboratory markers, notably CD4+ T cell phenotype markers, for their prognostic value in PSII. Chapter 1 provides an introduction into the cellular and molecular mechanisms of immunological self-tolerance and autoimmunity with a special focus on T cell activation and differentiation. Then, this section discusses the current knowledge of the processes leading to autoimmune disease, e.g. autoimmune uveitis, and outlines the foundations of immunosuppressive therapy. Chapter 2 presents on overview of the clinical features, diagnosis and current treatment of strategies for PSII. Characteristics of animal models of PSII, which represent a valuable tool in developing new therapies, are discussed as well as experimental treatment concepts in PSII patients. Chapter 3 describes the experimental methods applied in this thesis. This comprises the recruitment and clinical assessment of patients as well as methods for clinical and laboratory investigations. The flow cytometry analysis of peripheral blood T cell phenotype included cell surface markers (CD69, CD62L, chemokine receptors CXCR3, CCR4, CCR5), TCRzeta and intracellular cytokines (TNFalpha, IFNgamma, IL-10). Chapter 4 presents a randomised trial on the clinical and immunological effects of cyclosporin A (CSA) and tacrolimus in 37 patients with severe PSII requiring second line immunosuppression. Nine patients (50%) on CSA and 8 patients (42%) on tacrolimus showed an improvement of logMAR visual acuity of at least 0.2 within 3 months. CSA was found to be associated with a higher incidence of side effects, e.g. increase of mean arterial pressure and serum cholesterol.617.7206University of Aberdeenhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.409246http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU486816Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 617.7206
spellingShingle 617.7206
Greiner, Kathrin Heike
Medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation
description The studies in this thesis were aimed at developing new treatment concepts for PSII based on the understanding of the immunological mechanisms characterised in basic research. The intensity and prognosis of inflammatory disease determine the intensity of immunosuppressive therapy. In addition to clinical features, markers of effective immunosuppression are required to guide the immunosuppressive treatment in PSII patients, especially in those patients with opaque media. A secondary aim of this thesis was, hence, the evaluation of laboratory markers, notably CD4+ T cell phenotype markers, for their prognostic value in PSII. Chapter 1 provides an introduction into the cellular and molecular mechanisms of immunological self-tolerance and autoimmunity with a special focus on T cell activation and differentiation. Then, this section discusses the current knowledge of the processes leading to autoimmune disease, e.g. autoimmune uveitis, and outlines the foundations of immunosuppressive therapy. Chapter 2 presents on overview of the clinical features, diagnosis and current treatment of strategies for PSII. Characteristics of animal models of PSII, which represent a valuable tool in developing new therapies, are discussed as well as experimental treatment concepts in PSII patients. Chapter 3 describes the experimental methods applied in this thesis. This comprises the recruitment and clinical assessment of patients as well as methods for clinical and laboratory investigations. The flow cytometry analysis of peripheral blood T cell phenotype included cell surface markers (CD69, CD62L, chemokine receptors CXCR3, CCR4, CCR5), TCRzeta and intracellular cytokines (TNFalpha, IFNgamma, IL-10). Chapter 4 presents a randomised trial on the clinical and immunological effects of cyclosporin A (CSA) and tacrolimus in 37 patients with severe PSII requiring second line immunosuppression. Nine patients (50%) on CSA and 8 patients (42%) on tacrolimus showed an improvement of logMAR visual acuity of at least 0.2 within 3 months. CSA was found to be associated with a higher incidence of side effects, e.g. increase of mean arterial pressure and serum cholesterol.
author Greiner, Kathrin Heike
author_facet Greiner, Kathrin Heike
author_sort Greiner, Kathrin Heike
title Medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation
title_short Medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation
title_full Medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation
title_fullStr Medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation
title_full_unstemmed Medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation
title_sort medical treatment of autoimmune uveitis : clinical and laboratory investigations into new therapies for non-infectious posterior segment intraocular inflammation
publisher University of Aberdeen
publishDate 2004
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.409246
work_keys_str_mv AT greinerkathrinheike medicaltreatmentofautoimmuneuveitisclinicalandlaboratoryinvestigationsintonewtherapiesfornoninfectiousposteriorsegmentintraocularinflammation
_version_ 1718441571638050816